Catalyst Pharm Inc (CPRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 09-2015 | 06-2015 | 03-2015 | 12-2014 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 28,235 | 32,751 | 37,222 | 41,323 | 9,097 |
| Marketable Securities | 30,161 | 30,212 | 30,182 | 30,214 | 30,178 |
| TOTAL | $59,901 | $64,356 | $68,265 | $75,970 | $43,828 |
| Non-Current Assets | |||||
| PPE Net | 192 | 198 | 63 | 71 | 71 |
| Other Non-Current Assets | 9 | 9 | 9 | 9 | 9 |
| TOTAL | $200 | $207 | $72 | $80 | $80 |
| Total Assets | $60,102 | $64,563 | $68,337 | $76,050 | $43,908 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,794 | 817 | 1,316 | 1,051 | 1,814 |
| Accrued Expenses | 1,647 | 1,569 | 1,237 | 4,799 | 4,041 |
| TOTAL | $3,441 | $2,386 | $2,553 | $5,849 | $5,855 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 1,185 | 1,527 | 2,992 | 3,578 | 2,811 |
| TOTAL | $1,185 | $1,527 | $2,992 | $3,578 | $2,811 |
| Total Liabilities | $4,625 | $3,913 | $5,545 | $9,428 | $8,666 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 82,880 | 82,824 | 82,476 | 82,010 | 81,445 |
| Common Shares | 83 | 83 | 82 | 82 | 69 |
| Retained earnings | -90,076 | -84,261 | -79,811 | -75,253 | -69,843 |
| TOTAL | $55,476 | $60,650 | $62,792 | $66,622 | $35,242 |
| Total Liabilities And Equity | $60,102 | $64,563 | $68,337 | $76,050 | $43,908 |